# EDGAR Filing Document

**Accession Number:** 0000816956
**File Stem:** 0001127602-23-008749
**Filing Date:** 2023-3
**Character Count:** 7853
**Document Hash:** 05b541c494e2a42542d159c0e8c7abf0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-008749.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001127602-23-008749

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230301

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Jonas Daniel S
- **CENTRAL INDEX KEY:** 0001238334

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39218
- **FILM NUMBER:** 23705117

**MAIL ADDRESS:**
- **STREET 1:** C/O CONMED CORP
- **STREET 2:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER NAME:**
- **FORMER CONFORMED NAME:** JONAS DANIEL
- **DATE OF NAME CHANGE:** 20030603
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONMED Corp
- **CENTRAL INDEX KEY:** 0000816956
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **IRS NUMBER:** 160977505
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773
- **BUSINESS PHONE:** 727-214-2974

**MAIL ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONMED CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Jonas Daniel S<br><sub>(Last) (First) (Middle)</sub><br>C/O CONMED CORP<br>11311 CONCEPT BOULEVARD<br><sub>(Street)</sub><br>LARGO, FL 33773<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Special Counsel & Corp Secy_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CONMED Corp [ CNMD ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-01 |  | M |  | 2500 | A | $0 | 14784 | D |  |
| Common Stock | 2023-03-01 |  | F |  | 736 | D | $96.16 | 14048 | D |  |
| Common Stock | 2023-03-02 |  | M |  | 5400 | A | $59.96 | 19448 | D |  |
| Common Stock | 2023-03-02 |  | S |  | 5400 | D | $96.245 | 14048 | D |  |
| Common Stock | 2023-03-02 |  | M |  | 5000 | A | $78.76 | 19048 | D |  |
| Common Stock | 2023-03-02 |  | S |  | 5000 | D | 96.0762<sup>(1)</sup> | 14048 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Rsus (restricted Stock Units) | $0 | 2023-03-01 |  | M |  |  | 2500 | <sup>(2)</sup> | 2032-03-01 | Common Stock | 2500 | $0 | 0 | D |  |
| Rsus (restricted Stock Units) | $0 | 2023-03-01 |  | A |  | 3000 |  | <sup>(3)</sup> | 2033-03-01 | Common Stock | 3000 | $0 | 3000 | D |  |
| Options To Purchase Common Stock | $59.96 | 2023-03-02 |  | M |  |  | 5400 | <sup>(4)</sup> | 2028-03-01 | Common Stock | 5400 | $0 | 0 | D |  |
| Options To Purchase Common Stock | $78.76 | 2023-03-02 |  | M |  |  | 5000 | <sup>(5)</sup> | 2029-03-01 | Common Stock | 5000 | $0 | 5000 | D |  |

---

### Footnotes:

(1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

(2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.

(3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.

(4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

(5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

**Signature:** Daniel S. Jonas  
**Date:** 2023-03-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**